Connect with us

Health

Special formulation of inhaled niclosamide may be effective against SARS-CoV-2 – News-Medical.Net

Now in new research published on the preprint server bioRxix*, a novel formulation of the drug Niclosamide (NIC) is observed to be effective against SARS-CoV-2 and MERS-CoV in mouse models; it also protects against methicillin-resistance Staphylococcus aureu…

Published

on

Healthcare systems worldwide are overwhelmed by the raging COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the current number of global infections of SARS-CoV-2 nears 33 million individuals, an effective treatment or vaccine option is crucial and desperately needed.
The SARS-CoV-2 virus is related to the earlier coronaviruses of SARS-CoV and the Middle East respiratory syndrome-related coronavirus (MERS-CoV).  Now in new research published on the pre…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending